Articles by Michael R. McClung, MD

Effects of abaloparatide on bone mineral density and risk of fracture in postmenopausal women aged 80 years or older with osteoporosis

McClung, Michael R.; Harvey, Nicholas C.; Fitzpatrick, Lorraine A.; More

Menopause. ., Post Author Corrections: February 16, 2018

Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis: bone density, mass, and strength of the radius, and wrist fracture

Simon, James A.; Recknor, Christopher; Moffett, Alfred H. Jr; More

Menopause. 20(2):130-137, February 2013.

  • Editorial

Prevention of bone loss in postmenopausal women treated with lasofoxifene compared with raloxifene

McClung, Michael R.; Siris, Ethel; Cummings, Steve; More

Menopause. 13(3):377-386, May-June 2006.

Changes in bone density and turnover after alendronate or estrogen withdrawal

Wasnich, Richard D.; Bagger, Yu Z.; Hosking, David J.; More

Menopause. 11(6 Part 1 of 2):622-630, November-December 2004.